Regulation of intestinal regeneration: New insights

Microscopy Research and Technique

Volumn 51, Issue 2, 2000, Pages 129-137

  Thompson, Jon S ^a,b   Saxena, Shailendra K ^a   Sharp, John G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Epithelial cell migration; Intestinal regeneration

Indexed keywords

MAMMALS;

CELLULAR FUNCTION; EPIDERMAL GROWTH FACTORS; EPITHELIAL CELL MIGRATION; GROWTH REGULATION; INTESTINAL REGENERATION; LAMINA PROPRIA; MULTIPLE CELL TYPES; PATCH MODELS; REGENERATIVE PROCESS; REGULATORY FACTORS;

CELL DEATH;

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CELL MIGRATION; GROWTH STIMULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE WALL; LAMINA PROPRIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION;

EID: 0034668061     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20001015)51:2<129::AID-JEMT4>3.0.CO;2-Y     Document Type: Review

References (90)

1. Arbeit JM, Hirose R. 1999. Murine mentors: transgenic and knockout models of surgical disease. Ann Surg 229:21-40.
2. Autenreith IB, Bucheler N, Bohn E, Heinze G, Horak I. 1997. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 41:793-800.
3. Babyatsky MW, Rossiter G, Podolsky DK. 1996. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110:975-984.
4. Barnard JA, Bulus N. 1999. Heparin-binding EFG is a transforming growth factor β-regulated immediate early gene in intestinal epithelial cells. Gastroenterology 116:A538.
5. Barnard JA, Warwick GH, Gold LI. 1993. Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon. Gastroenterology 105:67-73.
6. Basson MD, Turowski G, Modlin IM, Madri JA. 1993. Butyrate-induced enterocyte differentiation and mucosal wound healing. Gastroenterology 104:A235.
7. Boismenn R, Havrau WL. 1994. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 266:1253-1255.
8. Bragg LE, Thompson JS. 1986. The influence of serosal patch size of the growth of small intestine neomucosa. J Surg Res 40:426-431.
9. Bragg LE, Thompson JS. 1989. The influence of intestinal resection on the growth of intestinal neomucosa. J Surg Res 46:306-310.
10. Bragg LE, Thompson JS, Hollingsed TC, Saxena SK. 1987. Contraction of serosa-patched intestinal defects. Curr Surg 44:388-390.
11. 3 on intestinal healing after injury by 5-Fluorouracil. Gastroenterology 106:A1019.
12. Bullard KM, Lund L, Mudgett JS, Mellin TN, Hunt TK, Murphy B, Ronan J, Werb Z, Bauda MJ. 1999. Impaired wound contraction in Stromelysin-1-deficient mice. Ann Surg 230:260-265.
13. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. Defective hematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845-1854.
14. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. 1994. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 94:376-383.
15. Donnet-Hughes A, Schiffrin EJ, Huggett AC. 1995. Expression of MHC antigens by intestinal epithelial cells. Effect of transforming growth factor-beta 2 (TGF-beta 2). Clin Exp Immunol 99:240-244, 1995.
16. Erdman SH, Park JHY, Thompson JS, Grandjean CJ, Hart MH, Vanderhort JA. 1989. Suppression of diamine oxidase activity enhances postresection ileal proliferation in the rat. Gastroenterology 96:1533-1538.
17. Fitzpatrick LA, Jakubowska A, Martin GE, Davis M, Jaye MC, Dionne CA. 1992. Acidic fibroblast growth factor accelerates the healing of acetic acid induced gastric ulcers in rats. Digestion 53:17-27.
18. Fritsch C, Simon-Assmann P, Kedinger M, Evans GS. 1997. Cytokines modulate fibroblast phenotype and epithelial-strom interactions in rat intestine. Gastroenterology 112:826-838.
19. Gughetta A, Nardi RV. 1992. PDGF-BB accelerates healing of indomethacin-induced gastric lesions in rats. Gastroenterology 102:A77.
20. Heldin CH, Miyazono K, Dijke PT. 1997. TGFβ signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-470.
21. Helmrath MA, Erwin CR, Warner BW. 1997. A defective EGF receptor in waved-2 mice attenuates intestinal adaptation. J Surg Res 69:76-80.
22. Helmrath MA, Shin CE, Erwin CR, Warner BW. 1998. EGF/EGF receptor axis modulates enterocyte apoptosis during intestinal adaptation. J Surg Res 77:17-22.
23. Hermiston ML, Wong MH, Gordon JI. 1996. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for non-autonomous regulation of all fate in a self renewing system. Genes Dev 10:985-996.
24. Jawhari AV, Balling AB, El Haj T. 1999. Cells at the edge of an ulcer undergoing epithelial restitution, down regulate E-cadherin and catenin expression and show no evidence of increased proliferation. Gastroenterology 116:A603.
25. Jones BA, Gores GJ. 1997. Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas and intestine. Am J Physiol 273:G1174-G1188.
26. Jung J, Zheng M, Goldfarb M, Zaret KS. 1999. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284:1998-2003.
27. Kato K, Chen MC, Nguyen M, Lehmann FS, Podolsky DK, Soll AM. 1999. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures. Am J Physiol 276:1105-1116.
28. Kessinger A, Sharp JG. 1999. Tissue engineering of the hematopoietic stem cell. In: Lanza R, Langer R, Vacanti J, editors. Principles of tissue engineering, 2nd ed. San Diego: Academic Press, p 631-641.
29. Komano H, Fujiura Y, Kawaguchi M, Matsumoto S, Hashimoto Y, Obana S, Mombearts P, Tonegawa S, Yamamoto H, Itohara S, Nanno M, Ishikawa H. 1996. Homeostatic regulation of intestinal epithelial by intraepithelial gamma-delta T cells. Proc Natl Acad Sci USA 92:6147-6151.
30. Korinek V, Barker N, Moerer P, Donselaav EV, Hulls G, Peters PJ, Clevers H. 1998. Depletion of epithelial stem cell compartments in the small intestine of mice lacking Tcf-4. Nature Genet 19:379-383.
31. Kucharzik T, Lugering A, Lugering N, Rautenberg K, Cichon C, Schmidt MA, Stoll R, Domschke W. 1999. Apoptosis of M cells during chronic intestinal ileitis in rats. Gastroenterology 116:A755.
32. Liu Yiw, Sanders MA, Basson MD. 1999. Loss of matrix-dependent cytoskeletal tyrosine kinase signals may regulate intestinal epithelial differentiation during mucosal healing. J Gastrointest Surg 3:82-94.
33. Longman RJ, Thomas MG, Poulson R. 1999. Trefoil peptides and surgical disease. Br J Surg 86:740-748.
34. Mahida YR, Beltinger J, Makh S, Goke M, Oray T, Podolsky DK, Hawkey CJ. 1997. Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclo-oxygense-1 and -2. Am J Physiol 273:G1341-G1348.
35. McKaig BC, Makh SS, Hawkey CJ, Podolsky DK, Mahida YR. 1999. Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF β3. Am J Physiol 276: G1087-1093.
36. McKinney SL, Jackson KA, Mi T, Goodell MA. 1999. Muscle derived cells can repopulate all hematopoietic lineage's of lethally irradiated mice. Blood 94:367a.
37. Miller KA, Dudgeon DL, Levine AD. 1999. Rapid induction of the cell cycle inhibitor, p21, after intestinal epithelial wounding: an integral component of wound healing. Gastroent 116:A 908.
38. Mowat AM, Viney JL. 1997. The anatomical basis of intestinal immunity. Immunol Rev 156:145-166.
39. Pender SLF, Quinn JJ, Sanderson IR, MacDonald TT. 1999. Matrix metalloproteinases: chromosomal regulation in human small intestine mesenchymal cells. Gastroenterology 116:A793.
40. Perner A, Rask-Madsen J. 1999. Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders. Aliment Pharmacol Therapeut 13:135-144.
41. Perr HA, Ye J, Gitelman SE. 1999. Smooth muscle expresses bone morphogenetic protein (Vgr-1/BMP-6) in human fetal intestine. Biol Neonate 75:210-214.
42. Podolsky DK. 1993. Regulation of intestinal epithelial proliferation: a few answers, many questions. Am J Physiol 264:G179-186.
43. Polk WH, Dempsey PJ, Russell WE, Brown PI, Beauchamp RD, Barnard JA, Coffey RJ. 1992. Increased production of transforming growth factor α following acute gastric injury. Gastroenterology 102:1467-1474.
44. Potten CS, Owen G, Hewitt D, Chadwick CA, Hendry H, Lord BI, Woolford LB. 1995. Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut 36:864-873.
45. Potten CS, Booth D, Haley JD. 1997. Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer 75:1454-1459.
46. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. 1999. Myofibroblasts I. Paracrine cells important in health and disease. Am J Physol 277:C1-C9.
47. Rampton DS, Collins CE. 1993. Review article: thromboxanes in inflammatory bowel disease-pathogenic and therapeutic implications. Aliment Pharmacol Therapeut 7:357-367.
48. 2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 100:375-379.
49. Robinson M. 1998. Medical therapy of inflammatory bowel disease for the 21st century. Eur J Surg (Suppl) 582:90-98.
50. Sandborn WJ, Hanauer SB. 1999. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflammatory Bowel Diseases 5:119-133.
51. Saxena SK, Thompson JS, Sharp JG. 1993. Intestinal regeneration. Medical Intelligence Unit. Austin, TX: RG Landes Co.
52. Saxena SK, Thompson JS, Sharp JG. 1997. Role of organized intestinal lymphoid aggregates in intestinal regeneration. J Invest Surg 10:97-103.
53. Schafer KH, Mestres P. 1999. The GDNF-induced neurite outgrowth and neuronal survival in dissociated myenteric plexus cultures of the rat small intestine decreases postnatally. Exp Brain Res 125: 447-452.
54. 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107:1137-1157.
55. 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985-1002.
56. Slavin J, Nash JR, Kingsnorth AN. 1992. Effect of transforming growth factor β and basic fibroblast growth factor on steroid impaired healing intestinal wounds. Br J Surg 79:69-72.
57. Stappenbeck TS, Wong MH, Saam JR, Mysorekar IV, Gordon JI. 1998. Notes from some crypt watchers: Regulation of renewal in the mouse intestinal epithelium. Curr Opin Cell Biol 10:702-709.
58. Suh E, Traber PG. 1996. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 16:619-625.
59. Tarnawski A, Stachura J, Sarfeh IJ, Sekhon S, Gergely H. 1992. Angiogenesis in gastric mucosa injured by ethanol: effect of epidermal growth factor, b-fibroblast growth factor and sucralfate. Gastroenterology 102:A176.
60. Tarnawski A, Santos AM, Stachura J, Sarfeh IJ. 1994. Sucralfate increases expression of EGF and its receptor in the margins of experimental gastric ulcer: A key to improved quality of ulcer healing. Gastroent 106:A194.
61. Thomas FT, Contreras JL, Bilbao G, Ricordi C, Cuviel D, Thomas JM. 1999. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery 126:299-304.
62. Thompson JS. 1987. Growth of neomucosa after intestinal resection. Arch Surg 122:316-319.
63. Thompson JS. 1990. Basement membrane components stimulate epithelialization of intestinal defects in vivo. Cell Tissue Kinetics 23:443-451.
64. Thompson JS. 1992. Effects of a smooth muscle antagonist on contraction of patched intestinal defects. J Surg Res 53:257-262.
65. Thompson JS. 1996. Differential effect of growth factors on intestinal wall components. J Surg Res 61:514-520.
66. Thompson JS. 1998. Somatostatin analogue predisposes enterocytes to apoptosis. J Gastrointest Surg 2:167-173.
67. Thompson JS. 1999. EGF inhibits somatostatin induced apoptosis. J Surg Res 81:95-100.
68. Thompson JS, Quigley EMM. 1991. Motor and absorptive function of the canine intestine following serosal patching. J Invest Surg 4:203-215.
69. Thompson JS, Vanderhoof JA, Antonson DL, Newland JR, Hodson PE. 1984. Comparison of techniques of growing small bowel neomucosa. J Surg Res 36:401-406.
70. Thompson JS, Vanderhoof JA, Davis SJ, Grandjean CJ. 1985. Effect of intestinal location on growth and function of neomucosa. J Surg Res 39:68-75.
71. Thompson JS, Tempero MA, Haun JL, Vanderhoof JA. 1986. The importance of luminal factors in neomucosal growth. J Surg Res 40:126-132.
72. Thompson JS, Sharp JG, Saxena SK, McCullagh KG. 1987. Stimulation of neomucosal growth by systemic urogastrone. J Surg Res 42:402-410.
73. Thompson JS, Hollingsed TC, Saxena SK. 1988a. Prevention of contraction of patched intestinal defects. Arch Surg 123:428-430.
74. Thompson JS, Saxena SK, Sharp JG. 1988b. Difluoromethylornithine inhibits urogastrone stimulation of neomucosal growth. J Surg Res 44:589-595.
75. Thompson JS, Saxena SK, Sharp JG. 1989. Effect of eflorithine on intestinal regeneration. Arch Surg 124:454-457.
76. Thompson JS, Bragg LE, Saxena SK. 1990. The effect of intestinal resection and urogastrone on intestinal regeneration. Arch Surg 125:1617-1621.
77. Thompson JS, Nguyen BT, Harty RF. 1993. Somatostatin analog inhibits intestinal regeneration. Arch Surgery 128:385-389.
78. Thompson JS, Saxena SK, Sharp JG. 1999. Difluoromethylornithine inhibits crypt fission. J Gastroentest Surg 3:662-667.
79. Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DL. 1998. Intestinal growth-promoting properties of glucagon-like peptide 2 in mice. Am J Physiol 273:E77-E84.
80. 2-induced hyperplasia of the rat small intestinal epithelium occur in the villous compartments. Gastroenterology 94:1335-1342.
81. van Deventer SJ. 1997. Review article: chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease? Aliment Pharmacol Therapeut 11 (Suppl 3):116-120, discussion 120-121.
82. Vattay P, Gyomber E, Morales RE, Szabo S. 1991. Effect of orally administered platelet-derived growth factor (PDGF) on healing of chronic duodenal ulcers and gastric secretion in rats. Gastroenterology 100:A180.
83. Walt RP. 1992. Misoprostol for the treatment of peptic ulcer and anti-inflammatory, drug-induced gastroduodenal ulceration. NEJM 327:1575-1580.
84. Wang JY, Viar MJ, Li J, Shi HJ, McCormack SA, Johnson LR. 1997. Polyamines are necessary for normal expression of the transforming growth factor-beta gene during cell migration. Am J Physiol 272:G713-720.
85. Wang J, Zheng H, Sung CC, Richter KK, Hauer-Jensen M. 1998. Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy. Am J Pathol 153:1531-1540.
86. Williams KL, Fuller CR, Mohapatra NK, Wang J, Fagin J, Lund PK. 1999. Enhanced growth of intestinal mucosa in SMP8-IGF-1 transgenic mice that overexpress IGF-1 in intestinal mesenchymal cells via the alpha smooth muscle actin promoter. Gastroenterology 116: A585.
87. Wolpert SI, Lally KM, Wang JY, Bass BL. 1999. Extracellular matrix modulates enterocyte growth via down regulation of c-jun but is independent of p21 and p27 expression. J Gastroint Surg 3:319-324.
88. Wright NA, Pike C, Elia C. 1990a. Induction of a novel epidermal-growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343:32-85.
89. Wright NA, Poulson R, Stamp GWH, Hall PA, Jeffery RE, Longcroft SM, Rio MC, Tomasetto C, Chambou P. 1990b. Epidermal growth factor induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 162:279-284.
90. Ziegler TR, Estivariz CF, Jonas CR, Gu LH, Jones DP, Leader LM. 1999. Interactions between nutrients and peptide growth factors in intestinal growth response and function. JPEN 23:5174-5183.